S&amp;P says may cut Chiron ratings
99249
Standard &amp; Poor&#39;s on Tuesday said it may cut Chrion Corp.&#39;s (CHIR.O: Quote, Profile, Research) debt ratings, after the company said it will not sell flu vaccine for the coming flu season due to problems at its plant in British.
181325
U.S. blue-chips eased on Friday after data showing moderate job creation in January suggested the Federal Reserve will not cut interest rates yet, while the S&P 500 and the Nasdaq edged higher.
689119
Fitch Ratings on Thursday cut Merck &amp; Co. Inc.&#39;s (MRK.N: Quote, Profile, Research) top &quot;AAA&quot; rating by two notches, citing its withdrawal of the arthritis drug Vioxx and subsequent
687265
The Federal Reserve cut a short-term interest rate yesterday to try to keep problems in the housing and mortgage markets from dragging the nation into recession, but Wall Street judged the move as too timid and financial markets tanked.
272184
NEW YORK -- Pfizer Inc. will probably slash staff and accelerate merger and licensing deals, as the pressure on it to improve its financial performance intensifies after the weekend's announcement that the company has ended development of a key drug.
704911
Facing continued top-line weakness, the company may have to cut costs.
251783
Credit ratings agency S&amp;P cut Russia&#39;s YUKOS (YUKO.RTS: Quote, Profile, Research) to default grade on Tuesday for missing a payment on a Western bank loan after
298156
Moody&#39;s Investors Service on Thursday said it may downgrade the debt ratings for Penn National Gaming Inc. (PENN.O: Quote, Profile, Research) and Argosy Gaming Co.
204822
Stocks edged lower on Wednesday after Standard & Poor's downgraded its rating outlook on several bond insurers, suggesting further potential turmoil in the financial sector.
451010
Stocks fell on Wednesday after credit ratings agency Standard & Poor's slashed its outlook on two companies that insure more than $1 trillion of debt, suggesting fallout from the housing slump is far from over.
565053
Standard &amp; Poor's downgraded its rating on Fidelity Investments parent FMR Corp. , citing lackluster performance at the Boston company's well-known mutual funds division. Standard &amp; Poor's analyst Charles D. Rauch said FMR faces "stagnant earnings and weak profitability" compared with peer investment companies, explaning why the rating on Fidelity's long-term notes was reduced to "AA-minus" from "AA." ...
414790
NEW YORK - Investors on Thursday will weigh the sharp retraction in stocks the day before as well as fears that the corporate profit picture is deteriorating.    Dow Jones futures fell 4 points recently, while Nasdaq futures were down 3 points and S&P futures dropped 0.20 points...
173189
Market analysts from both In-Stat and iSuppli have told BetaNews they will soon be issuing reports which cut the overall market outlook for Sony's PlayStation 3, and one analyst is cutting his estimate for the entire market.
326621
Chiron Corp. , which had to scrap its flu vaccine this season due to contamination, said on Friday it has received a warning from US regulators in connection with its shuttered vaccine manufacturing plant in England.
357715
Bear Stearns Cos Inc's  management shake-up could make the investment bank a takeover target, but the possibility of more write-downs and chance of legal entanglements from the subprime mortgage crisis could sideline suitors for now, analysts said on Tuesday.
81638
Chiron Corp. cut its 2004 earnings outlook Tuesday by more than $1 per share after British regulators suspended the drug maker&#39;s manufacturing license, preventing the company from selling its Fluvirin vaccine against influenza in any country this winter.
765776
Chiquita Brands International Inc.   CQB.N said on Monday it suspended its cash dividend and may   sell its shipping fleet, and warned that fallout from the   recent spinach scare will hurt quarterly profit, sending its   stock down more than 9 percent.